Full Press Release Details
Health Solutions Regains Compliance with NYSE
PALM BEACH, FL - January 8, 2026 - SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today
announced that the NYSE American ("NYSE") has accepted the Company's plan to regain compliance with the continued listing
standards in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
previously disclosed, NYSE notified the Company on October 14, 2025 that the Company had fallen below the NYSE's continued listing
standard requiring a listed company to have stockholders' equity of $4 million or more if the listed company has reported losses
from continuing operations and/or net losses in three of its four most recent fiscal years. With the NYSE's acceptance of the Company's
plan to regain compliance, the Company's listing is being continued pursuant to an extension with a targeted completion date of
July 14, 2026 (the "Plan Period"). The Company will provide quarterly updates to the NYSE American during the Plan Period
on its progress with the goals and initiatives outlined in the plan.
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such
as "believe," "expect," "intend," "aim," "plan," "may," "could,"
"target," and similar expressions are intended to identify forward-looking statements. These statements are based on current
expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those
expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals,
market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange
Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except
Health Solutions, Inc.
Cunningham, Chief Executive Officer
Strategic Communications
Pinto, Managing Director